Wockhardt

From WikiMD's WELLNESSPEDIA

Wockhardt is a global pharmaceutical and biotechnology company that has its headquarters in Mumbai, India. The company has manufacturing plants in India, UK, Ireland, France, and the US, and subsidiaries in various parts of the world.

History[edit]

Wockhardt was founded in 1960 by Habil Khorakiwala as a small pharmaceutical company. Over the years, it has grown into a multinational corporation with a diverse portfolio of products in the healthcare sector.

Business Operations[edit]

Wockhardt's business operations are divided into three main segments: Pharmaceuticals, Biopharmaceuticals, and Vaccines. The company's pharmaceutical division produces a wide range of generic and branded drugs for various therapeutic areas such as cardiology, diabetes, neurology, and gastroenterology. The biopharmaceutical division focuses on the development and production of biologic drugs, including biosimilars. The vaccines division is involved in the research, development, and production of vaccines for various infectious diseases.

Research and Development[edit]

Wockhardt has a strong focus on research and development (R&D), with several R&D centers in India and the UK. The company's R&D efforts are primarily focused on the development of new drugs and therapies, particularly in the areas of anti-infectives, biopharmaceuticals, and vaccines.

Regulatory Issues[edit]

In the past, Wockhardt has faced regulatory issues with the U.S. Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). These issues have primarily related to manufacturing practices at some of the company's facilities.

See Also[edit]

References[edit]


External Links[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Wockhardt&oldid=6616833"